home / stock / leas / leas quote
Last: | $0.0003 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0003 |
Close: | $0.0003 |
High: | $0.0003 |
Low: | $0.0003 |
Volume: | 25,200 |
Last Trade Date Time: | 06/20/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 25,200 | 06-20-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 5,000 | 06-13-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 1,000 | 06-12-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 2,500 | 06-10-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 40,000 | 06-05-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 470,000 | 06-04-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 500 | 05-30-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 25,000 | 05-28-2024 |
$0.0003 | $0.0003 | $0.0003 | $0.0003 | $0.0003 | 12,600 | 05-17-2024 |
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 20,000 | 05-16-2024 |
$0.0002 | $0.0001 | $0.0002 | $0.0002 | $0.0001 | 176,438 | 05-14-2024 |
$0.0002 | $0 | $0.0002 | $0 | $0 | 1 | 05-08-2024 |
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 500 | 05-03-2024 |
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 200,000 | 04-26-2024 |
$0.0002 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 1,000 | 04-25-2024 |
$0.0001 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 500,501 | 04-24-2024 |
$0.0027 | $0.003 | $0.0027 | $0.003 | $0.0025 | 681,510 | 04-19-2024 |
$0.0027 | $0.0056 | $0.0027 | $0.0056 | $0.0027 | 14,712,109 | 04-18-2024 |
$0.0055 | $0.0065 | $0.0055 | $0.0065 | $0.00325 | 16,848,081 | 04-17-2024 |
$0.00626 | $0.0073 | $0.00626 | $0.008 | $0.006 | 1,559,042 | 04-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
Strategic Asset Leasing Inc. Company Name:
LEAS Stock Symbol:
OTCMKTS Market:
Strategic Asset Leasing Inc. Website:
ANEW MEDICAL, INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD) Entered into a Definitive Merger Agreement PR Newswire ANEW MEDICAL is developing a platform and commercializing novel gene therapies to alleviate and/or reverse the progression of neurodegenerative...
Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease PR Newswire NEW YORK , March 13, 2023 /PRNewswire/ -- ANEW MEDICAL, INC . ("ANEW'' or the "Company"), a medical product development comp...